Anton van Den Ouden
Anton van Den Ouden has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Matthijs R. A. Welkers
Department of Medical Microbiology, Academic Medical Centre, Amsterdam, The Netherlands
2 shared publications - Anne Louise van Els
Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam, The Netherlands
1 shared publication - Gini Gc van Rijckevorsel
Centre for infectious disease control, National institute for public health and the environment (RIVM), Bilthoven, the Netherlands
1 shared publication Lydia Cr Fievez
Public Health Service Amsterdam, Dept. of Infectious Diseases, Amsterdam, The Netherlands
1 shared publicationM. Jonges
1 shared publication- Marcel Jonges
Amsterdam UMC location AMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 21 July 2022
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 27 (29) , 2200552
Paediatric monkeypox patient with unknown source of infection, the Netherlands, June 2022
Since May 2022, an international monkeypox (MPX) outbreak has been ongoing in more than 50 countries. While most cases are men who have sex with men, transmission is not restricted to this population. In this report, we describe the case of a male child younger than 10 years with MPX in the Netherlands. Despite thorough source tracing, a likely source of infection has not been identified. No secondary cases were identified in close contacts.
- 21 July 2022
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 27 (29) , 2200552
Open AccessPaediatric monkeypox patient with unknown source of infection, the Netherlands, June 2022
Since May 2022, an international monkeypox (MPX) outbreak has been ongoing in more than 50 countries. While most cases are men who have sex with men, transmission is not restricted to this population. In this report, we describe the case of a male child younger than 10 years with MPX in the Netherlands. Despite thorough source tracing, a likely source of infection has not been identified. No secondary cases were identified in close contacts.
- Open Access
- 30 June 2022
- Published by Springer Nature
Monkeypox virus whole genome sequencing using combination of NextGenPCR and Oxford Nanopore v1
Rapid genomic surveillance of monkeypox virus (MPXV) can provide valuable insights in order to guide public health interventions. Current sequencing protocols make use of direct Oxford Nanopore Sequencing. However, the obtained depth is a limiting factor which prevents multiplexing samples on a flowcell making sequencing very costly. Here, we provide the protocol for a PCR-based amplicon tiling approach (inspired by SARS-CoV-2 Midnight Protocol by Nikki Freed et. al. and the ARTIC network) for MPXV consisting of a total of 88 primer sets divided over 2 amplicon pools. The amplicon size is ~2,5kB. Our approach will increase the coverage (depth) significantly and allow for multiplexing up to 20 samples on a single Nanopore flowcell. In our experience clinical samples can be successfully sequenced with CT-values <25. Homopolymer regions will remain an issue in our approach, requiring manual curation of obtained consensus sequence genomes.
- 30 June 2022
- Published by Springer Nature
Open AccessMonkeypox virus whole genome sequencing using combination of NextGenPCR and Oxford Nanopore v1
Rapid genomic surveillance of monkeypox virus (MPXV) can provide valuable insights in order to guide public health interventions. Current sequencing protocols make use of direct Oxford Nanopore Sequencing. However, the obtained depth is a limiting factor which prevents multiplexing samples on a flowcell making sequencing very costly. Here, we provide the protocol for a PCR-based amplicon tiling approach (inspired by SARS-CoV-2 Midnight Protocol by Nikki Freed et. al. and the ARTIC network) for MPXV consisting of a total of 88 primer sets divided over 2 amplicon pools. The amplicon size is ~2,5kB. Our approach will increase the coverage (depth) significantly and allow for multiplexing up to 20 samples on a single Nanopore flowcell. In our experience clinical samples can be successfully sequenced with CT-values <25. Homopolymer regions will remain an issue in our approach, requiring manual curation of obtained consensus sequence genomes.